J9282 Mitomycin Intravesical Instillation - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Mitomycin Intravesical Instillation

Brand Name:

Zusduri

Strength:

1mg

HCPCS:

J9282

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Antitumor Antibiotic

Minor Drug Class:

Alkylating Agent/ Mitomycin

Oral (Y/N):

No

FDA Approval Year:

2025

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 2026

CMS Discontinuation Date:

Status:

In Use